Lasiosiphon kraussianus
Lasiosiphon kraussianus · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Lasiosiphon kraussianus is a botanical species of significant interest due to the unique chemical properties found within its root. Scientific investigations into this plant have focused on the isolation of specific compounds, most notably gnidilatidin and kraussianin. Researchers often utilize various root extracts to study the biological impact of these bioactive constituents. Preliminary studies suggest that certain preparations of the plant exhibit mutagenic activities under specific conditions. Consequently, understanding the chemical profile of this species remains crucial for ongoing toxicological research.
- Synonyms
- Gnidia Kerstingii · Gnidia Kraussiana · 18 more
- Common names
- Not available
- Family
- Thymelaeaceae
- Distribution
- Southern America
- Plant Parts
- Root
Classification
Synonyms
Lasiosiphon kraussianus is a botanical subject characterized by a complex history of taxonomic classifications. Throughout various studies, this plant has been identified under several different names, including the synonym Gnidia djurica. Researchers have also documented its relationship to Gnidia hoepfneriana and Gnidia kerstingii within scientific literature. Furthermore, the species is closely linked to the name Gnidia kraussiana, which remains a significant point of reference. This nomenclature also encompasses specific variations, such as Gnidia kraussiana var. glabrata, reflecting the intricate diversity of the taxon.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Lasiosiphon kraussianus is a unique botanical specimen belonging to the kingdom Plantae. Within this vast biological realm, the plant is classified under the class Equisetopsida. It further falls into the order Malvales, showcasing its specific evolutionary lineage. This species is a member of the genus Lasiosiphon, which helps distinguish it from related vegetation. Finally, its taxonomic placement is completed by its membership in the family Thymelaeaceae.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Malvales |
| Family | Thymelaeaceae |
| Genus | Lasiosiphon |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Lasiosiphon kraussianus is a plant species primarily distributed throughout the vast landscapes of the African continent. Its presence is most notable within East Tropical Africa, where it can be found spanning across Kenya, Tanzania, and Uganda. Beyond the eastern regions, the species also extends into Northeast Tropical Africa. Specifically, it inhabits the territories of Chad and the areas encompassing Sudan and South Sudan. This wide distribution highlights the plant's ability to thrive across diverse ecological zones in East and Northeast Africa.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Lasiosiphon kraussianus is a distinct herbaceous plant species that maintains a self-supporting growth habit. This herb exhibits a versatile size range, with individual specimens reaching a minimum height of only 0.1 meters. However, many plants within this species grow much larger, often starting at a minimum height of 2 meters. Under optimal conditions, the plant can achieve a maximum height of up to 3 meters. This variation in stature allows the species to adapt effectively to its specific environmental niche.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Lasiosiphon kraussianus, also known as Gnidia kraussiana, has been identified as exhibiting mutagenic activity in recent scientific evaluations. Researchers tested several medicinal herbs from Zimbabwe using various Salmonella typhimurium strains to assess their safety profiles. During these assays, the extract of this specific plant demonstrated mutagenicity toward the TA102 strain. Such findings are particularly significant because these botanical species are frequently utilized as traditional therapeutic agents. Understanding these biological interactions is essential for ensuring the safety of plants used in medicinal practices.
Compounds
Lasiosiphon kraussianus serves as a significant source of bioactive compounds with diverse pharmacological potential. Research into the plant's chemical constituents has revealed the presence of the daphnane-type diterpenoid gnidilatidin. This specific compound has demonstrated promising activity as an HIV-1 latency-reversing agent in recent studies. Additionally, the plant contains kraussianin, a member of the macrocyclic daphnane orthoester series. Together, these findings underscore the therapeutic importance of the species in both infectious disease and antineoplastic research.
Conditions
Lasiosiphon kraussianus, referred to in the research as Gnidia kraussiana, demonstrates significant potential in managing several biological and medical challenges. Its extracts serve as an effective insecticide against the pest Callosobruchus maculatus in stored seeds. The plant also shows medicinal promise in treating HIV-1 latency through the isolation of potent compounds like gnidilatidin. Furthermore, it exhibits antineoplastic activity capable of treating P-388 lymphocytic leukemia. Finally, the plant is identified as a rich source of compounds with potential activity for treating diabetes.
Preparations
Lasiosiphon kraussianus is prepared as an extract to facilitate various pharmacological and toxicological evaluations. In studies focusing on HIV-1 latency, the plant is processed into crude extracts using absolute methanol or 50% ethanol via maceration. These extracts are subsequently screened for their ability to reverse latency through specialized luciferase reporter assays. Additionally, the plant is prepared as extracts using a Soxhlet apparatus with distilled water for testing bacterial mutagenicity. This preparation method allows researchers to determine whether the plant's chemical constituents pose mutagenic risks to specific Salmonella typhimurium strains.
Parts used
Lasiosiphon kraussianus possesses a functional part root that serves as a primary source for chemical investigation. Research into this species has focused on the acetone and methanol extracts derived from its root system. These extracts have demonstrated significant activity against P-388 lymphocytic leukemia during various studies. Through bioactivity-directed fractionation, scientists have successfully isolated several potent daphnane orthoesters from these plant components. Notably, the discovery of the new compound kraussianin highlights the therapeutic potential found within the plant's root structure.